Literature DB >> 16049545

In vivo protective effects of urocortin on ischemia-reperfusion injury in rat heart via free radical mechanisms.

Chun-Na Liu1, Cui Yang, Xin-Yu Liu, Shengnan Li.   

Abstract

The aim of this study was to investigate the effects of urocortin (UCN) on oxidative stress and the mechanisms of urocortin on ischemia-reperfusion injury in vivo in the rat model. Thirty-six Sprague-Dawley rats were divided into 6 groups, including sham, control (normal saline solution), UCN1, UCN2, UCN3, and verapamil groups. The left anterior descending coronary artery of all rats except those in the sham group was treated with a 30-min occlusion followed by a 60-min reperfusion. Just before the occlusion, normal saline solution, UCN (5, 10, and 20 microg/kg body mass), or verapamil (1 mg/kg body mass) was administered. Heart rates, beating rhythm, and S-T segments were constantly monitored using an ECG. At the completion of the drug administration, blood samples were taken to measure the activity of superoxide dismutase (SOD), malonaldehyde (MDA), glutathione peroxidase (GSH-PX), and nitric oxide (NO) to evaluate the effects of UCN on oxidative stress. Finally, the size of infarction was measured. Arrhythmia rates were significantly lower, and the infarction size was significantly smaller (p < 0.01), in the UCN groups vs. the control group. Verapamil also significantly reduced arrhythmia rates and infarction size. The MDA activities were remarkably diminished, whereas the SOD, GSH-PX, and NO activities were significantly higher in the UCN and VER groups (p < 0.01). MDA, SOD, and NO activities were strongly correlated with UCN doses. These results suggest that UCN may play a protective role in ischemia-reperfusion injury in rat hearts against the oxidative stress by inhibiting free radicals' activities.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049545     DOI: 10.1139/y05-033

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  10 in total

1.  Corticotropin-releasing factor-2 activation prevents gentamicin-induced oxidative stress in cells derived from the inner ear.

Authors:  Johnvesly Basappa; Sevin Turcan; Douglas E Vetter
Journal:  J Neurosci Res       Date:  2010-10       Impact factor: 4.164

Review 2.  Corticotropin-releasing factor signaling and visceral response to stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Exp Biol Med (Maywood)       Date:  2010-10

Review 3.  Novel neuroprotective strategies in ischemic retinal lesions.

Authors:  Krisztina Szabadfi; Laszlo Mester; Dora Reglodi; Peter Kiss; Norbert Babai; Boglarka Racz; Krisztina Kovacs; Aliz Szabo; Andrea Tamas; Robert Gabriel; Tamas Atlasz
Journal:  Int J Mol Sci       Date:  2010-02-03       Impact factor: 6.208

4.  Urocortin ameliorates diabetic nephropathy in obese db/db mice.

Authors:  X Li; J Hu; R Zhang; X Sun; Q Zhang; X Guan; J Chen; Q Zhu; S Li
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

5.  Clinical perspectives of urocortin and related agents for the treatment of cardiovascular disease.

Authors:  Keiichi Ikeda; Kouki Fujioka; Yoshinobu Manome; Katsuyoshi Tojo
Journal:  Int J Endocrinol       Date:  2012-04-03       Impact factor: 3.257

6.  New targets of urocortin-mediated cardioprotection.

Authors:  Seán P Barry; Kevin M Lawrence; James McCormick; Surinder M Soond; Mike Hubank; Simon Eaton; Ahila Sivarajah; Tiziano M Scarabelli; Richard A Knight; Christoph Thiemermann; David S Latchman; Paul A Townsend; Anastasis Stephanou
Journal:  J Mol Endocrinol       Date:  2010-05-25       Impact factor: 5.098

7.  Systemic administration of urocortin after intracerebral hemorrhage reduces neurological deficits and neuroinflammation in rats.

Authors:  Hock-Kean Liew; Cheng-Yoong Pang; Chih-Wei Hsu; Mei-Jen Wang; Ting-Yi Li; Hsiao-Fen Peng; Jon-Son Kuo; Jia-Yi Wang
Journal:  J Neuroinflammation       Date:  2012-01-19       Impact factor: 8.322

8.  Urocortin ameliorates diabetic cardiomyopathy in rats via the Akt/GSK-3β signaling pathway.

Authors:  Xinyu Liu; Chunna Liu; Xiaoyan Zhang; Jiajun Zhao; Jin Xu
Journal:  Exp Ther Med       Date:  2015-01-23       Impact factor: 2.447

9.  Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure.

Authors:  Colin G Stirrat; Sowmya Venkatasubramanian; Tania Pawade; Andrew J Mitchell; Anoop S Shah; Ninian N Lang; David E Newby
Journal:  Br J Clin Pharmacol       Date:  2016-07-28       Impact factor: 4.335

10.  Urocortin I Protects against Myocardial Ischemia/Reperfusion Injury by Sustaining Respiratory Function and Cardiolipin Content via Mitochondrial ATP-Sensitive Potassium Channel Opening.

Authors:  Wei Liu; Liping Huang; Xue Liu; Li Zhu; Yan Gu; Wei Tian; Lin Zhang; Shengli Deng; Tian Yu
Journal:  Oxid Med Cell Longev       Date:  2022-03-29       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.